Eden Research (LON:EDEN) Insider Sean M. Smith Acquires 390,624 Shares

Eden Research plc (LON:EDENGet Free Report) insider Sean M. Smith purchased 390,624 shares of the business’s stock in a transaction that occurred on Wednesday, September 17th. The shares were purchased at an average cost of GBX 3 per share, with a total value of £11,718.72.

Eden Research Trading Down 4.8%

Shares of EDEN stock opened at GBX 2.71 on Thursday. The business’s fifty day moving average price is GBX 3.27 and its 200 day moving average price is GBX 3.27. The firm has a market capitalization of £14.46 million, a PE ratio of -753.33 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. Eden Research plc has a 1-year low of GBX 2.23 and a 1-year high of GBX 4.60.

Eden Research (LON:EDENGet Free Report) last posted its quarterly earnings results on Wednesday, September 17th. The company reported GBX (0.25) earnings per share (EPS) for the quarter. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%. As a group, sell-side analysts forecast that Eden Research plc will post -66.0000038 EPS for the current fiscal year.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Featured Stories

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.